Abstract 5775: Identification of SAR439859, an orally bioavailable selective estrogen receptor degrader (SERD) that has strong anti-tumor activity in wild-type and mutant ER+ breast cancer models
Maysoun Shomali(Sanofi (United States)), Monsif Bouaboula(Sanofi (United States)), Gary McCort(Sanofi (France)), Albane Courjaud(Sanofi (France)), Michel Tabart(Sanofi (France)), Joanne Lager(AVEO Oncology (United States)), Bruno Filoche-Rommé(Sanofi (France)), Dietmar Hoffman, Malvika Koundinya, Zhuyan Gou, Victoria M. Richon(Memorial Sloan Kettering Cancer Center), Laurent Schio(Sanofi (France)), Timothy Ackerson, Victor Certal(Universidade do Porto), Fabienne Thompson(Sanofi (France)), Jack Pollard(Sanofi (United States)), Laurent Debüssche(Sanofi (France)), Muchun Wang, Mikhail Levit, Rosalía Arrebola(Sanofi (France)), Carlos Garcia-Echeverria(Sanofi (France)), Michael I. Weinstein(Columbia University), Pierre-Yves Abécassis(Sanofi (France)), Laurent Besret(Sanofi (France)), Andrew Hebert, Sylvie Vincent(Takeda (United States)), Hong Chen, Karl Hsu, Chris Winter, Joonil Jung(Broad Institute), Jane Cheng(Beth Israel Deaconess Medical Center), Natalia Malkova(Pennsylvania State University), Fangxian Sun(Genomics Institute of the Novartis Research Foundation), Hui Cao(Universidade de Vigo), Jessica McManus, Frank Halley(Sanofi (France)), Patrick Cohen(Sanofi (France)), Francisco Adrián(HiFiBiO Therapeutics (United States)), Youssef El‐Ahmad(Sanofi (France))
Cited by 0
Related Papers
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
|Genome Research|2011|2k
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
|Proceedings of the National Academy of Sciences|2012|990
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833